CORRESP Filing
BioCardia, Inc.
Date: Sept. 16, 2025 · CIK: 0000925741 · Accession: 0001437749-25-029146
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290283
Letter
bcda20250916_corresp.htm
September 16, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: Joshua Gorsky
Re:
BioCardia, Inc.
Registration Statement on Form S-1
File No. 333-290283
Acceleration Request
Requested Date:
September 17, 2025
Requested Time:
4:30 p.m. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioCardia, Inc. hereby requests that its Registration Statement on Form S-1 (File No. 333-290283) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as we or our counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Austin D. March at (512) 338-5410.
Sincerely,
BIOCARDIA, INC.
Show Raw Text
CORRESP 1 filename1.htm bcda20250916_corresp.htm September 16, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Joshua Gorsky Re: BioCardia, Inc. Registration Statement on Form S-1 File No. 333-290283 Acceleration Request Requested Date: September 17, 2025 Requested Time: 4:30 p.m. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioCardia, Inc. hereby requests that its Registration Statement on Form S-1 (File No. 333-290283) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as we or our counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Austin D. March at (512) 338-5410. Sincerely, BIOCARDIA, INC. By: /s/ David McClung David McClung Chief Financial Officer cc: Peter Altman, Ph.D., BioCardia, Inc. Austin D. March, Wilson Sonsini Goodrich & Rosati